banapenem
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 14, 2015 (NCT03578588)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Bacterial beta-lactamase TEMINHIBITOR
Bacterial beta-lactamase TEM inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04200261 | Phase 1 | Dec 16, 2019 | Peking University, Sihuan Pharmaceutical Holdings Group Ltd. |
| NCT03570970 | Phase 1 | Mar 14, 2016 | Peking University, Sihuan Pharmaceutical Holdings Group Ltd. |
| NCT03578588 | Phase 1 | Dec 14, 2015 | Peking University, Sihuan Pharmaceutical Holdings Group Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Peking University | Academic/Hospital | 3 | 0 | 1 | 2015 |
| Sihuan Pharmaceutical Holdings Group Ltd. | For profit | 3 | 3 | 1 | 2015 |
2 organizations
Page 1 / 1